Drug intelligence / Profile preview

dixanthogen

Development stage: Discontinued
Modality: Small Molecules
Administration: Topical

Overview

Dixanthogen is an organosulfur compound belonging to the class of organic disulfides, with the chemical formula C6H10O2S4. It is a thiocarbonyl compound and functions as an ectoparasiticide, historically used topically for the treatment of scabies and other ectoparasitic infections[2][3][4][7]. Its mechanism of action involves acting as a parasite inhibitor, though detailed molecular targets are not well characterized. Dixanthogens are also formed by oxidation of xanthates and play a role in mineral flotation processes in industry[5][6][8]. The drug is no longer widely available for medical use.

Brand names: HerbisanSulfasan
Other names: AuligenBexidebisethylxanthogendiethyl dithiobis(thionoformate)diexanthogenethyl xanthogen disulfideO,O-diethyl dithiobis(thioformate)O,O-diethyl dithiobisthioformate

Beyond the preview

Go deeper on dixanthogen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on dixanthogen.

Explore the full profile